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Abstract
This article deals with recent changes in UK guidance on clinical waste, in particular a shift to dis-
posable, single-use instruments and sharps. I use interviews conducted with nurses from a GP
practice and two clinical waste managers at alternative treatment and incineration sites as a
springboard for reflection on the relationship between the legislation on clinical waste manage-
ment and its implementation. Scrutinizing the UK guidance, European legislation and World
Health Organization principles, I draw out interviewees’ concerns that the changed practices
lead to an expansion of the hazardous waste category, with an increased volume going to incin-
eration. This raises questions regarding the regulations’ environmental and health effects, and
regarding the precautionary approach embedded in the regulations. Tracing the diverse reverbera-
tions of the term ‘waste’ in different points along the journeys made by sharps in particular, and
locating these questions in relation to existing literature on waste, I emphasize that public health
rationales for the new practices are not made clear in the guidance. I suggest that this relative
silence on the subject conceals both the uncertainties regarding the necessity for these means of
managing the risks of infectious waste, and the tensions between policies of precautionary public
health and environmental sustainability.
Keywords Clinical Waste, EU Regulation, Hazardous Waste, Incineration, Medical Sharps
In 2006 the United Kingdom Department of Health issued new guidance on the manage-
ment of healthcare waste (Department of Health, 2006). This guidance made important
changes to previous advice on the management of such waste (Health Services Advisory
Committee, 1999); a significant impact in clinical settings was a shift to disposable, single-
use instruments, including sharps. The guidance emerges from a range of European Union
(EU) environmental, waste, and health regulations, themselves informed by World Health
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Organization (WHO) principles. These changes have received relatively little attention. In
the autumn of 2008, I conducted semi-structured interviews with two nurses from
a general practice (GP) surgery and two waste managers in England. In what follows
I describe the concerns that arise for these individuals in their encounters with clinical
waste—and with sharps in particular. I propose to use these conversations as a springboard
for reflections on larger questions regarding the relationship between legislation and imple-
mentation; and regarding the tensions between and within environmental and public health
regulations.
Clinical waste has been defined in the UK as waste produced in healthcare or related set-
tings that poses a risk of infection, or waste that may prove hazardous. (I discuss the chan-
ging definitions in more detail below.)1 It comprises bodily wastes, which is the subject of a
proliferating literature on our social, economic and ethical relationships to the tissues, sub-
stances and organs of myriad biotechnologies (e.g. Franklin and Lock, 2003; Scheper-
Hughes, 2002; Waldby and Mitchell, 2006). It also increasingly includes a wide range of
equipment that comes into contact with patients and healthcare workers—syringes, needles,
blades, specula, swabs, tubes, plasters and so on, items deemed risky as regards infection
and cross-infection.
Risk is of course a key rubric in clinical waste legislation and practice. I am interes-
ted here in how, in practice, some risks are emphasized in some contexts and then de-
emphasized in others; in how one kind of risk (e.g. an environmental one regarding
the ‘waste’ of plastic equipment) can be obfuscated in public health guidelines and in
the clinic to which these dictate, re-emerging later as a rhetorical force in an industrial
context, where these by-products of a public health emphasis on disposal become not so
much a problem as a valuable, and ethical, environmental resource. Much has been
written about the selectivity of individuals, policy-makers and legislators in assessing
risk; we tend to ignore certain risks, and to overemphasize others, worrying more about
air travel than about the cab-ride to the airport, or about terrorist attacks than about
the minutiae of government accountability—with, as Cass Sunstein (2002) has argued,
paradoxical and often harmful effects (see also Kahneman et al., 1982). What follows
touches upon this literature, in that I draw out how the UK legislation on clinical waste
shapes a lopsidedness in risk thinking that entrenches unacknowledged but problematic
tensions between public health and environmental concerns. It is also in conversation
with an intersecting scholarship on waste, dirt and pollution, scholarship that is curious
about what kinds of risks and dangers are conceptualized as such; that has emphasized
concepts of dirt, for example, as the effect of classificatory gestures of order-making;
and underscores the symbolic and ritual content and use of such orders and classifica-
tions (Douglas, 1995 [1966]; Douglas and Wildavsky, 1982; see also Bauman, 2004;
Hacking, 2003; Hawkins, 2006). And in thinking about the different roles and meanings
of ‘waste’ in two contrasting spaces inhabited by clinical sharps, I draw together, in
ways hitherto under-examined in the literature, the related, conflicted and obfuscated
stakes of public health and environmental discourse around these items.
1 It was only in the 1980s that clinical (or biomedical) waste began to be segregated from general waste.
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The general practice
In October 2008 I conducted a joint interview with a practice nurse and a nurse practitioner
from a GP surgery in England. I had explained to them that I was interested in discussing
recent changes in practices relating to disposable sharps. Sharps include needles, syringes
with needles attached, broken glass ampoules, infusion sets, scalpels and other blades—
items, in other words, that can cause cuts or puncture wounds.2 The WHO (2005: 568)
states that while sharps waste is ‘produced in small quantities’, it is highly infectious. It
also states (Pruess et al., 1998: 21–22) that contaminated sharps (particularly hypodermic
needles), along with concentrated cultures of pathogens, are: ‘probably the waste items
that represent the most acute potential hazards to health. Sharps may not only cause cuts
and punctures but also infect these wounds if they are contaminated with pathogens.’
Because of this double risk, they are considered a ‘very hazardous waste class’, with particu-
lar concern about HIV and hepatitis B and C infections through injuries from syringes nee-
dles contaminated by human blood (1998: 22). Sharps, if poorly managed, expose
healthcare workers, waste handlers and the community to infections. A review of HIV epi-
demiology in healthcare facilities in poor and rich countries of the world found an ‘alar-
mingly high’ rate of healthcare-worker-related infections in low-income countries
(Ganczak and Barss, 2008). Contaminated needles and syringes ‘represent a particular
threat and may be scavenged from waste areas and dump sites and be re-used’ (WHO,
2005: 568).3
The Hazardous Waste (England and Wales) Regulations 2005 classifies waste kinds
anew, in accordance with the European Waste Framework Directive (75/442/EEC), dis-
cussed further below. A new hazard group—‘H9’ (infectious waste)—in the regulations
covers substances containing viable microorganisms or their toxins, which are reliably
believed to cause disease in man or other living organisms. The 2006 Department of
Health guidance, The safe management of healthcare waste—which I shall refer to
henceforth simply as Safe management—divides clinical waste into two categories: waste
posing a risk of infection and medicinal waste. Clinical waste, it urges, must be segre-
gated from other types of waste. Separate systems are advised for sharps that are con-
taminated with cytotoxic/cytostatic medicinal products, and for sharps not thus
contaminated. Those not contaminated ‘may be treated to render them safe in suitably
licensed or permitted facilities prior to final disposal’; they should be placed in orange
receptacles, which take precisely those sharps that can be subjected to alternative treat-
ments, such as ‘plastic single-use instruments and non-medicinally contaminated sharps’,
while contaminated sharps:
. . . should be placed in suitably coloured receptacles (yellow/purple) and disposed of in
suitably authorized incineration facilities.. . . For sharps to be considered for alternative
treatments, the producer must demonstrate that they have robust segregation
procedures in place to separate those sharps that require incineration from those
2 Disposable syringes began to be manufactured and used in significant numbers in the middle of the twentieth cen-
tury. Uptake, however, was slow until the early 1990s, when concern about the spread of HIV and AIDS began to
change the landscape.
3 Concerns about scavenging recur in the media; see the Sunday Times (2009a, 2009b).
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suitable for alternative treatment. Where robust segregation of sharps contaminated
with cytotoxic or cytostatic products cannot be guaranteed, all sharps should be
incinerated. (Department of Health, 2006: 35)
These sharps go into yellow receptacles, which take waste requiring disposal by incineration
only, such as sharps with medicinal products or undischarged or partially discharged
sharps.4
The surgery in which the nurses worked had changed over in 2006 to the new system
outlined by the guidance published that year. The nurse practitioner explained that the
yellow sharps bins were for ‘any instruments or anything potentially sharp, anything
disposable—because everything is single-use items now’.5 The orange sharps bins for non-
contaminated sharps were not mentioned. Here, the nurses had decided to include, as
sharps, instruments for fitting and removing coils:
. . . these are quite long, and actually getting rid of them has been a bit problematic
because they won’t fit into an ordinary sharps bin, they’re too.. . . Well, we made an
assumption that we shouldn’t put them into the yellow bags because they’re hard
firm instruments and some of them are a bit pointy so we put them in the sharps
bins.
Thus the category of sharps requires significant interpretation, and is quite wide and
flexible. Moreover, an instrument’s disposability after a single use is not determined simply
by their being sharps; it also applies to ‘anything that comes into contact with a patient’. In
fact, it is also circular: the nurse practitioner stated that ‘anything disposable—because
everything is single-use items now’ goes into the sharps bins. Disposable items are disposed
of because they are disposable, and the sharps bins are their destination. It is not the nature
of these objects as sharps, or their potential infectiousness that determines, here, an instru-
ment’s marshalling into the sharps bin; it is disposability.
Before the new practices were introduced in this surgery, an autoclave was used for ster-
ilizing specula or any surgical instruments, which ‘was the norm in general practice’. The
nurse practitioner thought the changes were:
. . . because of CJD as well as HIV, but CJD was a big thing that made them change
to recommending single-use instruments. Although it’s not made in stone, you can
still have an autoclave, but you have to provide sort of evidence to the Infection
Control Team in yearly audits . . . to make sure you’re utilizing your equipment
properly.
Previously, you would have to test the autoclave every so often: ‘It was a hassle, wasn’t it?
It was really a hassle.’ With the autoclaves, the issue arose that items perhaps:
. . . weren’t being washed effectively, and the thing with CJD is you need to get rid
of the spores.. . . [I]t wasn’t just about sterilising them . . . it was about physically
getting rid of, brushing off things . . . so they suggested getting in these cleaners that
4 The suggestions in the guidance as to how to accomplish certain regulatory aims are not compulsory.
5 All the following quotations are taken from an interview conducted on 29 October 2008.
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you could immerse instruments in a special cleaner to agitate them and clean, but
they’re expensive . . .
The new practices become more obvious and feel more right as time goes on: many prac-
tices found that the cost of maintaining the autoclave was very high:
. . . at the end of the day it probably worked out the equivalent cost to get disposable
equipment . . . and you know that you’re doing the right thing, you know that you’re
not . . . there’s no sort of margin for error, you don’t use it on any other patient. . . .
I remember GPs having a little pot of sterilizing solution, there was probably no
evidence behind it that it was any good or doing anything, they’d just be soaking these
little earpieces, and I’m only going back a few years, just before I came here . . . three
years ago . . . GPs I was working with were just doing that, might still be doing that for
all I know . . . they weren’t the best . . .
The new practices ‘absolutely’ make sense; and it is:
. . . very simple now, you know what it is, you know it’s sterile, and you know it’s got
rid of immediately. It’s been out for 10–15 minutes, it’s gone.
A precautionary approach, in other words, has become second nature. The Nurse Practi-
tioner, describing a probe for syringing ears, explained that:
. . . you might use that . . . only for a few seconds . . . we used to re-use them, patient
after patient after patient, it was the norm to re-use them. And really, when you think
about it, there was no really stringent way of sterilizing them, so it’s good. It was awful
when you think about it, when you look back and you think ‘What a terrible thing’,
and it’s only a few years ago.
However, the instruments, designed to be disposable, and thrown away after a single
use, are of high quality: specula ‘used to be metal and we used to wash them’; the new dis-
posable ones are:
. . . amazing . . . when we first got them, we thought: ‘You can’t chuck that away after
you’ve used it once, it’s too good!’
Similarly with metal scissors that are thrown away after one use:
. . . they’re really good, they cut really well . . . mouthpieces for people blowing into a
machine, we just chuck them away . . . everything’s disposable.. . . When we were
talking [with others in the practice] about your research, they were saying ‘What a
waste of the metal’; when you think about, it’s kind of, we need to do it, for cross-
infection, it needs to be done, but then it doesn’t fit comfortably with recycling and
everything, although we do try and recycle paper and stuff here.
The practice nurse explained that they used to let the yellow sharps bins ‘get to three-
quarters full, didn’t we, but then we’ve been told recently to do it [i.e. dispose of the bins]
more often than that’. The nurse practitioner concurred:
Yes, there’s some infection control guidelines through from [the] PCT [primary care
trust] that . . . recently we had to do an Infection Control Audit and one of the things
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they said was that we had to change the yellow bags daily. I did question that, because
throughout the summer it’s so quiet here, there may be nothing, there might be one
little thing in the bottom of the bin, and they did say just use our own, use your
common sense, but they wanted us to change them regularly.
Moreover, the plastic packaging that the each disposable instrument comes individually
wrapped in goes into the general waste.
Incineration
The sharps boxes are placed in a large lockable container outside the surgery; the local
council does a weekly pick-up, transporting the boxes to treatment and incineration sites.
In December 2008 I visited a small site for alternative treatment of hospital waste, where
soft waste was treated prior to going to landfill. The sharps boxes that arrive here courtesy
of the local council (from sites that include the surgery I visited) are put aside (‘quaran-
tined’) and then transported to a major incineration plant nearby, run by a multinational
waste management organization with a significant presence in the UK. The site manager
(referred to henceforth as RL) at the alternative treatment site told me that the system of se-
gregating sharps at source from other clinical waste is imperfect, with needles turning up in
the bagged waste.
From here, the sharps end up at a large incineration plant, where I was shown around
the domestic and clinical waste incinerator facilities. The organization that runs this plant
describes itself as providing: ‘integrated waste management and environmental services to
local communities and industry’. Running services such as refuse collection, recycling, waste
treatment and street cleaning for 100 UK local authorities, it employs 12,500 employees and
runs 123 landfills and 6 ‘energy recovery facilities’. The clinical operations manager here
(whom I shall refer to as CG) emphasized the environmental nature of his organization:
the waste incinerated here gets re-used for energy, as the incineration process generates elec-
tricity, and the ash from the process is re-burnt to make aggregates (from which roads are
built). What is more, the metal (e.g. surgical stainless steel from clinical waste) is extracted
after incineration and recycled. The organization’s website does not in fact mention incin-
eration, emphasizing rather the organization’s role in reducing dependence on landfill and
in cutting emissions of greenhouse gases by enabling energy recovery and producing renew-
able energy for the National Grid, which reduces the use of fossil fuels.
CG, however, told me that clinical waste is ‘a minefield’—partly because there are not
enough incinerators to process the sharps: there are only 14 in the UK, with many having
shut down because of costs.6 CG sees more hazardous waste coming for incineration
because all manner of waste is ‘lumped together’ as hazardous.
6 Many hospital onsite incinerators judged inefficient were closed down from the 1990s onwards, with the NHS
having exported wastes off-site to private contractors. Tudor et al. (2005) state that the UK Environmental Pro-
tection Act ushered in a greater segregation of healthcare waste and stricter requirements for incinerators accept-
ing such waste. High costs of implementing these restrictions led to the closure of several incineration plants in the
late 1990s (Tudor et al., 2005). According to a 2005 article in Waste Management, the number of: ‘licensed and
operational incinerators continues to decrease. The ownership of the clinical waste incineration capacity in the UK
is now dominated by two private companies’ (Fisher, 2005: 572).
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One reason for this expansion of hazardous waste is cost-related: it is more expensive,
said CG, for hospitals to segregate different kinds of clinical waste rigorously. The Safe
management of healthcare waste, as we saw, states that
For sharps to be considered for alternative treatments, the producer must demonstrate
that they have robust segregation procedures in place to separate those sharps that
require incineration from those suitable for alternative treatment. Where robust
segregation of sharps contaminated with cytotoxic or cytostatic products cannot be
guaranteed, all sharps should be incinerated. (Department of Health, 2006)
In the surgery I visited, there were no orange boxes which could take those sharps that
can be subjected to alternative treatments rather than incineration. This is not seen by every-
one in the chain of clinical waste management as a problem: the strategic waste manager of
the local council told me: ‘You shouldn’t be seeing the orange boxes, everything pretty much
should be going in the yellow boxes.’ He recounted giving blood and the sharps being put in
an orange box: ‘but they had no way of knowing that the blood was not infected, so they
shouldn’t have done that’.7 A second reason for the expansion of hazardous waste may
therefore be a precautionary public health attitude—to which I shall return below.
A third reason is the expansion of the category of hazardous waste. Cytotoxic sharps used
to be processed before going to landfill, but now go to incineration as hazardous waste. More
sharps are therefore incinerated. Technically, many of these sharps would not be considered
hazardous but nonetheless go into the hazardous waste stream for incineration. This expand-
ing of the boundaries of hazardous waste applies not just to sharps. Wood, explained CG, is
treated with creosote, so it has to go to incineration. Some perfumes are hazardous, others
not; it is complicated for producers (whose responsibility it is) to work out which is and which
is not, so all types get put together as hazardous. The result is that more items are incinerated.
Other kinds of waste also emerge. Both RL and CG expressed concern over the sharps
boxes getting incinerated along with their contents. RL, at the alternative treatment site,
described his attempts to devise a system whereby this plastic can be recycled; there is a finan-
cial incentive—the plastic ‘can go for £400 a tonne’. And incinerating the boxes requires ‘more
wasting of emissions’. CG is also preparing a shredding project; the sharps bins are not neces-
sarily full when they arrive: ‘A box with 2 sharps going to incineration is wasteful’ (note the
echo with the nurses being instructed to empty the boxes before they are three-quarters full);
a shredder project would reduce the volume by 15 percent before incineration. Both managers
also were concerned with the possibility of stripping down packaging and raw materials to be
diverted from incineration—yet again, they said, costs compromise this possibility.
Regulations
The UK Controlled Waste Regulations of 1992 had defined clinical waste as waste produced
in healthcare or related settings that poses a risk of infection, or waste that may prove
hazardous. It is:
7 Telephone interview, 11 November 2008.
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‘(a) any waste which consists wholly or partly of human or animal tissue, blood or other
bodily fluids, excretions, drugs or other pharmaceutical products, swabs or dressings,
syringes, needles or other sharp instruments, being waste which unless rendered safe may
prove hazardous to any person coming into contact with it; and (b) other waste arising
from medical, nursing, dental, veterinary, pharmaceutical or similar practice, investiga-
tion, treatment, care, teaching or researching, or the collection of blood for transfusion,
being waste which may cause infection to any person coming into contact with it.’
In July 2005, the Hazardous Waste (England and Wales) Regulations 2005 replaced the
Special Waste Regulations in England and Wales. (The Special Waste Regulations remain in
place in Scotland, but now include clinical waste as special waste.) These regulations (which
I’ll refer to henceforth as HW Regulations), made under the Environmental Protection Act
of 1990, were designed to implement the European Hazardous Waste Directive (91/689/
EC). The Directive’s requirements were in fact already largely transposed in England under
the special waste regime—through the requirements that movements of hazardous waste be
documented in consignment notes, and that records of disposal and recovery of such waste
be kept. The HW Regulations, however, replaced the domestic special waste regime with a
more transparent transposition of EU obligations by referring instead to hazardous waste.
Along with the Landfill (England and Wales) Regulations 2002 and the List of Waste
(England) Regulations 2005, the Hazardous Waste Regulations require that producers ade-
quately describe their waste using a written description and the appropriate European
Waste Catalogue (EWC) codes.
The EWC codes are a list of wastes produced by the European Commission in accordance
with the EuropeanWaste Framework Directive (75/442/EEC), in order to provide common ter-
minology for describing waste throughout Europe. The Directive incorporated the European
Hazardous Waste List pursuant to the Hazardous Waste Directive (91/689/EEC). Each mem-
ber state has discretion regarding the means by which Directives’ aims are enacted.8
Under the previous Special Waste Regulations, much of the responsibility for the waste
fell on the consignor—the person causing the waste to be removed from the premises where
it was held (this may be the waste management contractor rather than the person producing
the waste). The HW Regulations instead shifted the focus of control and responsibility fur-
ther up the waste management chain from waste managers to waste producers.
The regulations define hazardous waste (HW) as waste containing hazardous properties
that may render it harmful to human health or the environment. They stipulate a range of
recording, identifying and tracking procedures with which those who dispose of, collect
or transport waste must comply. HW is tracked from source to final disposal. Different cat-
egories of HW must not be mixed together, and nor must HW be mixed with non-HW. The
regulations shift the regulatory focus from administration to assessment of compliance, with
emphasis placed on the waste producer.
The adoption of the new hazard group ‘H9’ (infectious waste) in the HW Regulations
means that more clinical waste is likely to be classified as hazardous. In fact the use of
the EWC codes has resulted in clinical waste being by definition classified as hazardous
8 For the role of Europe as a principal engine of health and safety regulations affecting the UK, including in hazards
and environmental matters, see Majone (1997) and Baldwin (1996).
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waste. A Department for Environment, Food, and Rural Affairs (DEFRA) Final Regulatory
Impact Assessment of the Hazardous Waste Regulations notes that: ‘implementation of
the revised Hazardous Waste List will significantly increase the number of hazardous waste
producers, and the number of hazardous waste consignments’ (2005: 3).
The guidance on the Safe Management of Healthcare Waste introduces several key
changes:
* The introduction of a new term, ‘healthcare waste’, defined as waste from natal care,
diagnosis, treatment or prevention of disease in humans/animals.
* The division of clinical waste into two categories: waste posing a risk of infection, and
medicinal waste.
* The classification of medicinal waste into two categories: cytotoxic and cytostatic
medicines, and medicines other than these.
* The definition of infectious waste as waste that contains viable microorganisms or
their toxins, which are known or reliably believed to cause disease in man or living
organisms, and a method for its classification. Clinical waste that is non-medicinal is
therefore co-extensive with infectious waste.
* The introduction of a new term ‘offensive/hygiene waste’, defined as non-infectious, non-
hazardous waste which does not require specialist treatment or disposal, but which may
cause offence to those coming into contact with it. This waste type includes waste pre-
viously described as ‘human hygiene’ or ‘sanpro’ (sanitary towels, tampons, nappies).
The guidance urges that clinical waste be segregated from other types of waste and be treated/
disposed of appropriately in suitably permitted, licensed or exempt facilities on the basis
of the hazard it poses. (The HW Regulations place a duty on waste producers to segregate
hazardous and non-hazardous waste at source.)
The EWC codes classify waste whose collection and disposal is subject to special require-
ments in order to prevent infection as hazardous. If waste is infectious, it is subject to such
requirements, and is therefore hazardous waste by definition. Waste previously known as
‘clinical waste’ on the basis of infection risk is thus infectious waste, which is hazardous.
The Safe management guidance states that: ‘if an item of healthcare waste is considered
to pose a risk of infection it should be considered clinical waste, it should be classified as
hazardous waste and should be transported as an infectious substance’ (Department of
Health, 2006). Only infectious waste requires treatment at specialist facilities; therefore, if
waste is being sent to a facility to render it safe, disinfect, sterilize or incinerate it due to
its infectious nature, it should be considered infectious waste.
Note here that this phrasing suggests that the guidance is concernedwith helping individuals
to recognize infectious waste who lack an understanding of the grounds on which a type of
waste may be considered infectious. It emphasizes, that is, how to reason backwards from
the way the waste is being managed, to its classificatory identity. I will return to this below.
Precautions
As I explained above, the recent changes in clinical waste management emerge from
European Directives on waste. Underlying this European legislation are international
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agreements and principles, in particular the formulations of the World Health Organization,
which outline four principles relating to healthcare waste:9
(1) The duty of care principle: ‘any organisation that generates waste has a duty to
dispose of the waste safely’. It is ‘the HCF [healthcare facility] that has ultimate
responsibility for how waste is containerized, handled on-site and off-site and
finally disposed of’.
(2) The polluter pays principle states that: ‘all waste producers are legally and financi-
ally responsible for the safe handling and environmentally sound disposal of the
waste they produce. . . . If pollution results from poor management of health-care
waste then the HCF is responsible. However, if the pollution results because of
poor standards at the treatment facility then the HCF is likely to be held jointly
accountable for the pollution with the treatment facility. The fact that the polluters
should pay for the costs they impose on the environment, is seen as an efficient
incentive to produce less and segregate well’.
(3) The precautionary principle states that: ‘one must always assume that waste is haz-
ardous until shown to be safe’. Where it is ‘unknown what the hazard may be, it is
important to take all the necessary precautions’.
(4) The proximity principle recommends that ‘treatment and disposal of hazardous
waste take place at the closest possible location to its source’, in order to minimize
the risks involved in its transport.
The WHO also cites the Basel Convention as guiding its policy on healthcare waste. This
Convention aims to: ‘minimize the generation of hazardous wastes in terms of quantity and
hazardousness; to dispose of them as close to the source of generation as possible; to reduce
the movement of hazardous waste’. A central goal of the Convention is to: ‘protect human
health and the environment by minimizing hazardous waste production whenever possible’.
It means addressing the issue through an ‘integrated life-cycle approach’ involving ‘strong
controls from the generation of a hazardous waste to its storage, transport, treatment, reuse,
recycling, recovery and final disposal’.10
The four principles—like the UK guidance—place the onus on the waste generator to
refrain from endangering the public. This onus, in the form of liability for irresponsible man-
agement of waste, fosters the precautionary approach that is also one of the WHO principles.
The precautionary principle has been very influential in policy and regulation at the European
level especially, and in particular in environmental policy. The principle can be formulated in
various ways, and can be used both to justify decisive action and inaction. At its core, however,
it states that regulatory and legislative steps should be taken against potential harms, even
when causal relationships between particular actions and harmful outcomes are not clear,
and when we do not know if those harmful outcomes in fact result.11 However, as Cass
9 See http://www.healthcarewaste.org/en/128_hcw_categ.html (‘The ten categories of health-care risk waste’) and
http://www.healthcarewaste.org/en/130_hcw_intagreemts.html (‘Two international agreements’) on the WHO
website (accessed February 2009).
10 Quotes in this paragraph are from the WHO website: http://www.healthcarewaste.org/en/130_hcw_intagreemts.
html (‘Two international agreements’, accessed February 2009).
11 See for example Sunstein (2005). On the precautionary principle, see also Adams (2000).
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Sunstein has underlined, precautions against some risks have consequences, some of
which may themselves constitute other risks. The combined effect of the onus being
placed on the producer and the salience of a precautionary approach (which aim to
reduce the health risks of healthcare waste) is to undermine attempts to produce less
healthcare and general waste. It also undermines the attempt to segregate waste care-
fully. One example is the shift to disposable single-use instruments, which in itself gen-
erates more packaging waste (a problem given the lacklustre market for recycled and re-
usable plastic in the UK), countering the aspiration to minimize waste in general within
the NHS. The Department of Health states that:
. . . waste does not have to be disposed of: it can be reviewed for its resource value and
potential.. . . [The NHS] now more than ever needs to be prudent with its use of
resources and to save money wherever opportunity permits. Materials or equipment
deemed to be waste can often be a valuable commercial commodity elsewhere:
consider potential for recovery, reuse or recycling.. . . Waste, irrespective of its disposal
method has the potential to pollute land, air and water. In order to protect the
environment, measures such as prevention, minimisation and recycling should be
explored. (Department of Health, 2008)
Similarly, the classification of hazardous waste (of which infectious waste is a compon-
ent) is widened to include more types of waste. And a precautionary approach on the
ground—as we saw with the practice nurses—results in more items being placed into the
hazardous waste stream. As they said: ‘You know that you’re doing the right thing.. . .
There’s no margin for error.’ Segregation is a tricky business in which, because of public
health priorities and their own liability, waste producers would rather be safe than sorry.
The precautionary approach that is indeed part of nursing practice and part of the new guid-
ance may caution against including sharps in ordinary waste for fear of health risks
incurred; but it also helps to drive waste that might not be hazardous into the hazardous
waste stream. As CG (at the incineration plant) emphasized, the hazardous waste stream
has expanded.12 And the disposal techniques—specifically, incineration—that deal with
such waste are not uncontroversial.
Incineration
The number of incinerators has grown in Europe in the last decade. In the UK, however,
landfill has been more widely available than incineration. The EU Landfill Directive (imple-
mented in the Landfill [England and Wales] Regulations 2002) shifted the territory, requir-
ing the UK to implement a landfill tax and the Landfill Allowance Trading Scheme,
designed to reduce the release of greenhouse gases produced by landfills through the
use of alternative waste treatment methods. Incineration is playing a growing role in
the treatment of municipal waste and in energy supply in the UK, although, as noted above,
12 The DEFRA Final Regulatory Impact Assessment stated that it is estimated that: ‘if all clinical waste was to be
classified as infectious under the hazard property H9, this would make the costs to the NHS in England in the
region of £90m per annum compared to £50m now’ (2005: 20).
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many incinerators have closed down and capacity is a problem. The Landfill Directive pro-
hibited the landfilling of infectious hospital and clinical waste from medical or veterinary
establishments. The Landfill Regulations require all waste to be treated before landfill for
new and hazardous waste sites from July 2004—with the aim of reducing its quantity or
the hazards it poses to human health or the environment. They also prohibit the co-disposal
of hazardous and non-hazardous wastes by the same date.
The incineration plant I visited downplays incineration in its promotional materials; the
clinical operations manager was emphatic that incineration was not a significant problem,
underscoring the company’s role in ‘energy recovery’, renewable energy and reduction of
landfill. Incineration is framed, that is, as environmentally responsible. The Environment
Agency, in a position statement on Waste incineration in waste management strategies in
October 2003, states that ‘we live in a throw-away society’, with each household generating
around 1.2 tonnes of waste every year in England and Wales:
We must urgently find affordable solutions to the management of municipal waste
that minimise its effect on the environment including human health and maximise
its use as a resource.. . . [W]e need to start creating less waste, recycle more and
dispose of the remainder in a safe and environmentally friendly way.. . . [I]
ncineration has a role in waste management . . . it may be appropriate for local
authorities to include incineration in a particular strategy provided that it does not
undermine the prevention or minimisation of waste, or other waste management
options such as re-use, recovery or recycling [and that] it represents the Best
Practicable Environmental Option (BPEO) for managing the specific waste stream.
(Environment Agency, 2003a)
The Environment Agency monitors emissions concentrations of pollutants such as
sulphur dioxide, oxides of nitrogen, carbon monoxide and volatile organic compounds.
Since 1996, it states, there have been substantial cuts in emissions from incinerators in
cadmium, lead and dioxin emissions. Research on the health effects of municipal waste
incinerators was based on emissions from older incinerators that had much higher
pollutant emissions levels. The agency: ‘is not aware of any studies that conclusively
link adverse health outcomes to incinerator releases’. The Department of Health’s inde-
pendent advisory Committee on the Carcinogenicity of Chemicals in Food Consumer
Products and the Environment (COC) advised in 2000 that it is not possible to conclude
that the small increase in primary liver cancer documented was due to emissions of pol-
lutants from incinerators; ‘any potential risk of cancer due to residency (for periods in
excess of 10 years) near to municipal incinerators was exceedingly low and probably
not measurable by the most modern epidemiological techniques’ (Environment Agency,
2003). In 2008, the Environment Agency states that space in landfill is limited: ‘and
more waste will have to be diverted away from landfill to comply with the
EU Landfill Directive’. Since 1990, it states, emissions to air have fallen. ‘Incinerators
also produce ash that may be recycled; for example, in aggregates’ (Environment
Agency, n.d.).
There have indeed been technological advances in incineration since the 1970s. Propo-
nents of incineration argue that problems regarding dioxins can be technically solved, and
that—as the company I visited suggests—the generation of electricity reduces the use of
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fossil fuels, contributing to a net reduction in the greenhouse effect. Moreover, it is claimed
that incineration emissions are insignificant in relation to total air pollution in developed
economies, and that toxins can be reduced by separating plastics from the rest of the waste
stream through recycling (see Gandy, 1993).
Incineration, on this view, is a solution to the risks associated with landfill. However, the
Environment Agency’s confidence notwithstanding, concerns about incineration remain, in
particular about dioxins and furans (Gandy, 1993: 35–38, 1994; Gille, 2007: 157–159).13
The WHO itself makes a characteristically cautious assessment, noting that small-scale
incinerators operate at temperatures (below 800 C) that: ‘may lead to the production of
dioxins, furans, or other toxic pollutants as emissions and/or in bottom/fly ash’ (WHO,
2005: 568). Long-term:
. . . low-level exposure of humans to dioxins and furans may lead to impairment of the
immune system, and impaired development of the nervous system, the endocrine
system and the reproductive functions. Short-term high level exposure may result in
skin lesions and altered liver function.
However, while dioxins are classified by the International Agency for Research on Cancer
as a ‘known human carcinogen’, most of the evidence documenting the toxicity of dioxins
and furans is:
. . . based upon studies of populations that have been exposed to high
concentrations of dioxins either occupationally or through industrial accidents.
There is little evidence to determine whether chronic low-level exposure to dioxins
and furans causes cancer in human. Overall, it is not possible to estimate the global
burden of diseases from exposure to dioxins and furans because of large areas of
uncertainty. (2005: 568)
A complex and inconclusive picture, then. However, the emphasis on incineration as
‘energy recovery’ extends the concept of recycling so as to address environmental concerns
while taking for granted the existing waste stream. Energy recovery from incineration is
not waste reduction, pre-consumer recycling, or product re-use (elements of the UK Waste
Hierarchy),14 but rather the recovery of energy from post-production and post-consumption
waste. The use of incineration plants integrated into combined heat and power systems
does not, therefore, challenge the growing waste stream, but deals with already existing
pollutants (Gandy, 1994: 18–21). This ‘recycling’—in the form of energy recovery
from waste—therefore potentially causes increased risks, given concerns about the environ-
mental and health risks of incineration. Public health concerns, as implemented through a
precautionary approach, and where segregation is constrained by questions of costs, lead
to an increased waste stream and increased volumes of incineration.15
13 Kaiser et al. claim that: ‘pollutants with the potential to have harmful effects on human health have been iden-
tified with health care waste. Two of these substances, mercury and dioxin, have been detected in significant
amounts in air and ash emissions from medical waste incinerators’ (2001: 205).
14 See DEFRA: http://www.defra.gov.uk/environment/waste/topics/ (accessed February 2009)
15 This situation is not dissimilar to one described by Tim Cooper (2009) regarding seventeenth-century Britain,
where frequently sources of environmental and health nuisances were themselves attempts to use waste products
(Cooper, 2009).
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Environmental historians have thus argued that the notion of recycling has been co-
opted into technocratic responses to environmental critiques, responses which preserve
the pursuit of economic growth and its concomitant growth in waste. Waste is cast as
a source of raw materials, an opportunity rather than an environmental problem—an
approach first emphasized by Victorian recycling enthusiasts proclaiming that there
was no such thing as waste (Cooper, 2009). Consumption itself, that is, is not queried.
Contemporary waste management has focused on market-based policy initiatives; since
the 1970s, waste has been demunicipalized in the UK, with private companies dominat-
ing waste management. This phenomenon, argues Matthew Gandy, works against a
focus on recycling or the reduction of waste in production and consumption. The regu-
latory environment, in the form of landfill taxes for example, has failed to have a signi-
ficant impact on recycling costs or on a re-use ethos. The focus on incineration—an
‘end-of-pipe’ technology—sits uncomfortably with a sustainability agenda. Waste is
seen as an endless industrial and financial resource whose profitability disincentivizes
a concern with waste production.
The raising of emissions standards on health and environmental grounds by Western
countries has also had paradoxical effects: it is now almost impossible to site new incinera-
tion facilities in countries regulated by new emissions standards (such as the UK). As Zsuzsa
Gille writes:
Wastes are transported for treatment to those countries that have the loosest
emissions standards, until the regulations in the country or region ‘catch up’ with
those of others. The gap in regulatory standards is also a key cause of hazardous
waste exports from Western Europe to developing countries and to Eastern Europe.
(2007: 158)
An emphasis on rapid disposal has been characteristic of thinking about waste since
the nineteenth-century’s ‘refuse revolution’ (Cooper, 2007). Growing industrialization
and urbanization in Britain during that century led to waste production outstripping its
re-use, re-consumption, recycling. A growing sense of crisis developed into a critique of
capitalist claims of progress, with filth and capitalism seen as disturbingly intertwined.
The sanitary and public health movements were responses to the challenge of waste, and
emphasized the need to remove rather than re-use waste, since proximity to it was
health-threatening. Recycling—prolific before waste became a significant problem—
returned as a solution to polluting wastes, for example in the form of attempts to recycle
sewage waste. This solution, however, was one that reconciled capitalist progress with
limited natural resources. And since the late nineteenth century, argues Tim Cooper
(2009), recycling has consistently been represented as an innovative technological solution
to problematic waste production.
Here we see the entangled relationship of public health and waste disposal. ‘The
privileging of public health in decisions on how to treat urban waste was one of the
key reasons why disposal triumphed over reuse in municipal waste management,’ writes
Cooper (2009). Public health concerns urge us to dispose of waste. However, the solu-
tions to the health problems of waste have had worrisome consequences, as in the
over-reliance on landfill. Moreover, the public health concerns about waste run counter
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to the aspirations to waste minimization and indeed recycling (where recycling is taken
to mean re-use rather than energy recovery from waste). So while end-of-pipe technolo-
gies may sit uncomfortably with sustainability, as environmental historians have argued,
sustainability itself sits uncomfortably with public health and the precautionary principle
which shapes policy. And this is a tension manifested in the management of clinical
waste in particular.
Waste, biomedical rationales and sustainability
Clinical waste is effectively treated, regulatorily and discursively, as an unproblematic
component of hazardous waste to be disposed of as dangerous. This is problematic,
for it eclipses the tensions that exist in principle between the drive to minimize, re-
use, or recycle waste, and the drive to minimize as far as possible the potential risks
to health posed by clinical waste. An environmental agenda urging a shift from a culture
of disposability within the healthcare sector, as in any other realm, comes up with
a bump against a precautionary public health agenda. The guidance encouraging
clinical waste producers to treat as hazardous those healthcare wastes that pose a risk
of infection—and placing the onus on producers to make this assessment—works against
guidance encouraging facilities to reduce waste: the options for re-using or recycling
needles are limited to say the least. We have seen, in the case of the practice nurses,
how a precautionary approach becomes second nature and ethically compelling. Infec-
tion control priorities urge the nurses to let sharps bins get only three-quarters full,
with the result that more sharps boxes are incinerated; but this, and the increase in
packaging through use of disposable instruments, seem to many to be an acceptable
cost.16 The choice becomes that between taking undue health risks by not disposing of
hazardous waste appropriately, and being over-precautionary with waste that is poten-
tially hazardous. In other words, the reflex towards rapid disposal and the precautionary
reflex overlap. The so-called ‘throw-away’ culture is closely intertwined with a precau-
tionary public health regime. The question of sustainability then becomes a potential
threat to the primacy of public health.
Waste minimization in healthcare settings is hampered by a tendency to perceive all
healthcare waste as contaminated (Tudor et al., 2005). It is, of course, not all contami-
nated, but is also not known to be uncontaminated, hence the sway of precautionism.17
Sustainable waste management is, argue Tudor et al.: ‘a difficult challenge for the UK,
where the traditional approach has been to concentrate on disposal to a cheap landfill
and government supported recycling’ (2005: 607). Waste management practices in the
NHS, they write, have displayed a lack of strategic waste minimization planning that
would involve long-term scrutiny of the question of waste. ‘Holistic waste management’
is at a low level in the NHS. The authors argue for a movement away from the concept
16 An audit of anaesthetic waste collected from six theatres in one teaching hospital in the UK found that only
4 percent by weight of the sharps bins content was true sharps waste (needles and broken glass); 57 percent
was glass and 39 percent was ‘other’ (packaging, plastic, metal and fluid). See Hutchins and White (2009)
and British Medical Journal (2009).
17 Another obstacle is the lack of viable markets for recyclables in parts of the UK.
T H E P R E C A U T I O N S O F C L I N I C A L W A S T E j
j
197
of ‘waste management’ to one of sustainable decision-making regarding resource use
(e.g. packaging waste). Important measures include tackling waste at generation,
through implementation of ‘greener’ forms of procurement, and the investigation of
local purchasing and the ‘take back’ arrangements with suppliers. What this article
does not spell out, however, is the core tension between policy regarding public health
risks and policy regarding waste. How does one minimize waste without counteracting
the precautionary principle that is at the heart of policy around clinical waste as a
subset of hazardous waste?
The problem that clinical waste management poses to the sustainability and recycling
agenda is much elided in the guidance, legislation, and literature I have scrutinized.
I noted above that the UK guidance is not very explicit or informative about the grounds
on which certain kinds of waste are to be classified as infectious and hazardous; the rea-
soning it encourages waste handlers to engage in is bureaucratic, making inferences on
the basis of how waste is dealt with rather than engaging with biomedical rationales.
Such rationales for waste classification and procedures are rather elusive in the Safe man-
agement of healthcare waste (Department of Health, 2006) document—the document
which the nurses and the incineration managers I spoke with invoked as their reference
point for procedure. This document explains the changes in classification and disposal
of clinical waste in terms of alignment with ‘hazardous waste regulation and guidance
published by the regulatory agencies’, stating that the previous classification of clinical
waste was ‘no longer felt to be appropriate’, not easily equating ‘to the use of the Euro-
pean Waste Catalogue Codes’ now mandatory for all waste transfer documentation
(Department of Health, 2006: 1). One has to work back to the EU legislation, and
indeed the WHO documentation, to find more significant information on rationales for
aspects of the legislation and guidance.
A document published by the Environment Agency in 2003, before the new system was
put in place (Technical guidance on clinical waste management facilities) did provide some
information on the risks of clinical waste: ‘the potential microbiological risks associated
with clinical waste may be unfamiliar, and their assessment may sometimes require expert
advice’; and clinical waste ‘has the potential to cause offence, for example, human body
parts. Past incidents of inappropriate disposal of, for example, sharps and anatomic waste
have caused public concern.’ Moreover, ‘the perceived risks and potential for offence
make it undesirable to open containers of clinical waste to inspect the contents’ (Environ-
ment Agency, 2003b: 19).
[W]here clinical waste is collected under a manual bag handling system, rather than
contained in larger rigid packaging, there are risks of needlestick injury and infection
from spillages or incorrectly packaged waste to all those involved in the chain from
point of production to final disposal. (2003b: 24)
Municipal waste:
. . . contains higher numbers of microorganisms capable of causing respiratory illnesses
and gastro-intestinal infections, for example Escherichia coli and Salmonella
enteritidis. The frequency of pathogenic viruses such as HIV and hepatitis B is higher
in clinical waste, whereas the frequencies are similar for both waste types for
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microorganisms capable of causing skin and soft tissue infections such as
Staphylococcus aureus and Streptococcus pyogenes. (2003b: 74)
The possibility of harm to those handling the waste; the possibility of unauthorized
materials recovery, particularly of sharps, and the ethical inappropriateness of some wastes,
for example body parts, for landfill disposal, all make landfill of limited acceptability
for clinical waste disposal (2003b: 69). For risks to be realized to health and/or the
environment—for example, for HIV, hepatitis B or C infection to develop from a needle-
stick injury—pathogens must be present; they must be released from containers or processes;
they must survive and be mobile after release; they must be present in sufficient numbers;
there must be a pathway to the host; the host must intake the pathogen; the host must be
susceptible to the pathogen; the host must not take prophylaxis.
The risk assessment will determine the likelihood of these events taking place, the
controls needed at waste management facilities, and the requirement for environmental
monitoring and for site decontamination at completion. This will need to be done on a
site specific basis and where there is uncertainty a precautionary approach may be
justified. It must be recognised that an infected ‘host’ may spread the disease to the
community and the environment, so harm may not be localised. (2003b: 74, italics
added)
‘Where there is uncertainty, a precautionary approach may be justified.’ This sentence
indicates the spirit in which clinical waste guidance has been and is being taken—and argu-
ably must be taken, given practical constraints on risk assessment and a public health ori-
entation reluctant to take any risks. A sense of the difficulties facing anyone making a
decision as to whether a particular waste poses a risk is conveyed by the document’s follow-
ing claim:
. . . the question of what is infectious is not absolute. . . . The decision as to whether
a waste may be infectious must therefore be based upon one or both of: a clinical
judgement; the source of the waste. The first of these may not be available in a
tangible form to the waste holder or regulator to assist them to make a decision
with certainty that they will, respectively, avoid prosecution or secure a conviction.
The latter can offer more certainty, but means treating waste as infectious whether
it is or not. It may also be difficult, for example, for a regulator faced with
potentially illegally deposited waste to establish what its original source was
(2003b: 75–76)
It is very difficult to establish on-site whether waste is infectious or not; it is therefore more
‘certain’—and more ethical?—to treat waste as infectious whether it is or not.
The WHO provides more detail than the UK guidance on the health grounds for
waste management systems. In 1998 it published a document called Safe management
of wastes from healthcare activities (Pruess et al., 1998). It states that a range of kinds
of infections can be caused by exposure to healthcare waste, including gastroenteric
infections such as Salmonella, Vibrio cholerae (faeces and/or vomit); respiratory infec-
tions such as Mycobacterium tuberculosis and the measles virus (inhaled secretions or
saliva); genital infections such as the herpes virus (genital secretions); skin infections
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such as Streptococcus spp (pus); AIDS (blood and sexual secretions); septicaemia
(blood), viral hepatitis A, B and C (blood, faeces and body fluids). There is particular
concern about infection with HIV and hepatitis viruses B and C, for which there is
strong evidence of transmission via healthcare waste (generally through injuries from
syringe needles contaminated by human blood). Concentrated cultures of pathogens
and contaminated sharps (particularly hypodermic needles) are ‘probably the waste
items that represent the most acute potential hazards to health. Sharps may not only
cause cuts and punctures but also infect these wounds if they are contaminated with
pathogens.’ Because of this double risk: ‘sharps are considered as a very hazardous
waste class’ (Pruess et al., 1998: 21–22).
Individual cases of accidents—occurring especially to healthcare workers—and sub-
sequent infections caused by healthcare waste are well documented, but the:
. . . overall situation, however, remains difficult to assess, especially in developing
countries. It is suspected that many cases of infection with a wide variety of pathogens
have resulted from exposure to improperly managed healthcare wastes in developing
countries. (1998: 24)
The document discusses the rates of injuries from sharps for healthcare personnel, and the
survival of different pathogenic microorganisms in the environment (the hepatitis B virus
can survive for several weeks on a surface, and is resistant to brief exposure to boiling
water, where HIV is much less resistant). Bacteria are less resistant than viruses, and
‘much less is known about the survival of prions and agents of degenerative neurological
diseases’, such as CJD, ‘which seem to be very resistant’.
[V]ery few data are available on the health impacts of exposure to health-care
waste, particularly in the case of developing countries. Better assessment of both
risks and effects of exposure would permit improvements in the management of
health-care waste management [sic] and in the planning of adequate protective
measures. Unfortunately, the classical application of epidemiology to the problem is
difficult because of methodological complications and uncertainties regarding
evaluation of both exposure and health outcome. The great diversity of hazardous
wastes that can be involved and of circumstances of exposure is a particularly
problematic feature of all such evaluations. It prevents not only the development of
a unified analytical approach to the assessment of exposure and health outcome but
also the generalization of any statistical inferences drawn about a specific waste-
exposed population. . . . Within health-care establishments, the surveillance of
infection and record-keeping are important tools that can provide indications of
inadequate hygiene practices or of contamination of the immediate environment
(including that caused by health-care waste). Surveillance allows an outbreak of
infection to be recognized and investigated and provides a basis for introducing
control measures, for assessing the efficacy of those measures and of the routine
preventive measures taken by the establishment, and for reducing the level of
avoidable infection. (Pruess et al., 1998: 28–29).
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In other words, surveillance and record-keeping are important not because they can avert
risks that are known in detail, but because they are a means to manage an as yet rather un-
known quantity—and possibly to yield further data.
The document concludes by stating that: ‘further research is necessary to increase
knowledge of: the extent to which health-care waste is contaminated; the risk level for
contamination of the exposed population by digestive, respiratory, and percutaneous
routes’, and ‘growth and survival of pathogens in waste during storage’ (1998:
28–29). The suggestion is thus that there is a lot more we could know about the risks
of clinical waste. The unknowns relating to clinical waste—the unknowns left unspoken
by the UK guidance—are reiterated in a statement by the WHO in a 2005 special edi-
tion of Waste Management on the management of healthcare wastes. This article states
that healthcare activities:
. . . lead to the production of waste that may lead to adverse health effects. Most of this
waste is not more dangerous than regular household waste. However, some types
of healthcare waste represent a higher risk to health. These include infectious waste
(15–25% of total healthcare waste), among which are sharps waste (1%), body part
waste (1%), chemical or pharmaceutical waste (3%), and radioactive and cytotoxic
waste or broken thermometers (less than 1%). (WHO, 2005: 568)
It explains that sharps waste, although produced in small quantities, is highly infectious,
exposing health workers, waste handlers and the community to infections if it is poorly
managed. It points out the healthcare waste management options ‘may themselves lead
to risks to health’ and that ‘no perfect readily achievable solution to manage healthcare
waste exists’ (2005: 568). Indeed, the problem is not only that the desire to manage the
risks of clinical waste increases waste, but that the desire to investigate these risks, if
carried out in such a way as not to cause further risks of health, can also increase
such waste (and its risks). The WHO states that until ‘countries in transition and devel-
oping countries have access to healthcare waste management options that are safer to
the environment and health, incineration may be an acceptable response when used
appropriately’ (2005: 569). Therefore, it is implied, incineration is not ideal. And one
of the WHO’s medium-term strategies is to conduct ‘risk assessment to compare the
health risks associated with: (1) incineration; and (2) exposure to healthcare waste’
(2005: 569). This latter claim is intriguing; it acknowledges that not enough is known
about either of these risks to know whether the costs associated with incineration are
worth paying for the benefits in strict regulation of exposure to healthcare waste.
And, in effect, what this raises is the possibility that the precautionary principle, when
applied to healthcare waste, is in fact counterproductive—if, in managing healthcare
waste, it is sending more waste to incineration.
It also suggests that part of what is at work here is what Lianos and Douglas (2000)
have called ‘dangerization’, whereby future events and interactions are conceived in
terms of danger, rendered subject to a system of automatic controls that seek to extract
the danger in question and foster safety, which is understood as the normal state. More-
over, the legislation presents the question of clinical waste management not as a ques-
tion about real, actual or concrete harms; its rhetorical drive is rather that of an
unarticulated and symbolic threat of pollution that, intuitively, must be averted at all
T H E P R E C A U T I O N S O F C L I N I C A L W A S T E j
j
201
costs. Ian Hacking (2003) notes, that in the years since Douglas and Wildavsky’s (1982)
groundbreaking work, the topography of risk has changed. Discussing what he calls
‘sectarian groups’ concerned with pollution, he points out that ‘perceived risk and dan-
ger are not essential to them’ (2003: 46). I suggest that something similar operates in the
clinical waste guidance and the practices it enjoins. The mandatory nature of managing
the risks of clinical waste rings out loud and clear; and, as I suggest above, a precaution-
ary principle becomes internalized in those on the ground who unwrap the plastic items
and throw them into the sharps bins after a single use. However, what kinds of risk they
pose, and how, remains obscure, almost irrelevant, black-boxed within the enactment of
procedures that, despite their opacity, are understood as a moral imperative of good
public health. The point is not that there are no real risks in clinical waste—as Dou-
glas’s work underscored, literal pollution can be invested with symbolic content. But
quite what these are is not conveyed, nor explicitly related to the practices enjoined in
the guidance.
Conclusion
As a recent British Medical Journal editorial (2009) recently stated, the direct contribution
of the health sector to environmental degradation is not well analysed and debated. In addi-
tion, the relationship between the different regulatory priorities governing waste in general,
hazardous waste, and the specific subset that is healthcare waste—a relationship which is, as
we have seen, complicated and potentially conflicting—is not drawn out within the legisla-
tion and guidance I have discussed. The same applies to the larger question of the relation-
ship between (hazardous) waste disposal and public health guidelines, perhaps especially
those making use of a precautionary framework. The relative silence within the UK legisla-
tion on these points of tension reveals the lack of attention being drawn to the important
question of the relationship between different regulatory and governance priorities and
mechanisms. The silence within the documentation, however, is undone by the vivid ways
in which these tensions are manifest in practices on the ground, at both ends of the waste
journey: in the ‘disposal’ of clinical waste in a surgery and the ‘disposal’ at incineration.
In both these locations, the problematic status of clinical waste as waste—as something un-
wanted, to be discarded and disposed of, or as something that is being wasted, not re-used
or even not prevented from coming into existence in the first place—is highly visible. The
nurses I spoke with were ambivalent about the immediate disposal of resources that, while
being good materials, are treated as hazardous waste. They were, however, happy to err on
the side of caution. Both CG and RL expressed a desire to turn wastes back into resources.
When everything is a risk, everything becomes waste to be disposed of. Waste
expands, as we have seen, to include ever more objects. The items themselves are harder
to see as resources; and yet the process of energy recovery from waste quarries a
resource from such waste. We may worry that this ‘waste’ relies upon its production,
and fails to query the wastefulness with which ‘waste’ is both produced and not re-
used. We may worry about the environmental and health effects of the increased hazard-
ous waste stream. We may worry, in other words, about sustainability. But when does
sustainability trump the avoidance of healthcare sector risks? Or when does avoiding
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healthcare sector risks trump concerns with sustainability? These are questions which we
must ask when tracing the ambivalent journeys of disposables and sharps from the
nurse’s office to the incineration plant.
Gay Hawkins (2006) has, like many other writers on waste, written that its simplest def-
inition is discarded, expelled or excess matter. She writes that:
. . .waste is at the heart of so many moral economies that it’s hard to find a sense in
which it isn’t bad. To be unproductive or to excessively expend is a sign of poor
discipline and irresponsible conduct. Minimizing waste in the interest of efficiency
is regarded as evidence of an effective economy: industrial, moral, and psychic.
(2006: viii)
Hawkins approaches waste (as does Bauman, 2004) from the angle of consumption, and
she argues that contemporary waste habits ‘have become connected to the practice of virtue’
(p. ix). A pleasure emerges associated with efficient marshalling, separation, and recycling
of waste to environmental ends.
This understanding is unsatisfactory in relation to clinical waste. In the clinical, public
health context, we must ask whose efficiency and whose virtue is relevant, and to what
end? Where Hawkins speaks of the injunction to ‘waste not, want not’, the figure of clinical
sharps in the legislation instead urges us, precisely, to ‘waste’ on ethical grounds. Public
health efficiency—where what reigns is the desire to avert infection, and to be able to trace
those infections that do occur—requires instead a systematic disposal of material, a disposal
which sits uncomfortably with the green mantra of ‘reduce, re-use, recycle’. Public health
virtue locates the ethical crux of the matter not in an efficient use and re-use of material,
or in unnecessary consumption; it locates it instead in seeing ever more items as ‘waste’—
matter to be separated. In so doing, it creates an ethical injunction to ‘waste’. Public health
efficiency, then, crucially involves ‘waste’.
It is thus helpful to distinguish ‘waste’ in the sense of the material that is deemed in
excess, from ‘waste’ as the act of squandering something of potential value. This distinction
is especially important when thinking about clinical waste rather than other kinds of waste.
The special ethical injunctions relating to sharps raise the interesting question of a dual eth-
ics of waste: the ethical imperative of wasting—squandering—on public health grounds, and
ethical imperative of not wasting, through an industrial rhetoric of ‘energy recovery’ of the
very items that are now so routinely disposed of.
Disposable sharps are a way to avert risk, in part through a logic of the audit trail.
Disposing of them—wasting their material—is morally imperative. But it also represents
a waste, an ethically problematic disposal in a culture addicted to throwing things away.
This waste, however, also represents an opportunity to intervene in this wasteful culture,
through the virtue of industrial recovery and a rhetoric of environmental harm minim-
ization through incineration rather than landfill. While the cost of disposable sharps
must exercise NHS managers, the value represented by the disposable sharps market,
and by the increase in waste to incineration, is someone else’s value. Again: whose
waste—and whose value?
I stated earlier that, in the nurses’ practice, it is not the nature of sharps as sharps, or
their infectious risk, that determines their fate in the sharps bin—it is their disposability.
Where Hawkins (2006) writes about the virtues and pleasures of recycling, sharps—in the
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clinical context—invoke instead the virtues and pleasures of disposal, a routine of ethical
risk management. They suggest an injunction against the exhortation to reduce waste and
to re-use material; they provoke an injunction for the act of wasting. Here, the ‘waste’
(the matter) is a danger, and the act of wasting an ethical value. And yet, downstream at
the incineration plant, they invoke the alchemical virtues and pleasures of re-use, of trans-
formation and ‘recovery’. The same waste, now rendered safe, with public health virtue
ensured, is a source of considerable physical and ethical value. The wasting of waste has
not, so to speak, been a waste.
The growth in recent legislation on clinical waste makes it an important object of scru-
tiny. Given that, as Ian Hacking puts it, risk management: ‘has taken on a duchy in corpor-
ate structure and, to a lesser extent, in the more disorganized and hands-on approaches of
politicians and governments’ (2003: 32), one important issue regarding clinical waste is
therefore the efficiency and joined-up-ness of public health and environmental logic. More-
over, though, the way in which sharps figure differently—and contradictorily—in different
locations, within different public health and environmental discourses, is testament to the
myriad uses to which particular objects—and rather symbolic ones at that—can be put
within a policy context. Sharps convey different virtues at different points in their short
lives, moulding themselves to different policy discourses. The language of the legislation
and guidance I have examined fosters a rather closed public health discourse in which the
proliferation of clinical waste is not framed as a significant problem; the environmental con-
cerns that figure prominently in other legislation and other NHS guidance remain outside of
view. The opacity of the rationales for the guidance speaks to an uncertainty about, and ten-
sion between, the two different rubrics of infection control and environmental hazard. This
uncertainty and tension sits uncomfortably with the exhortative legislation regarding both,
and makes itself felt in the engagement of my interviewees with the now eminently—and
imperatively—disposable sharps.
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